These effects cannot be blocked by EGF- and TNFa-treatment alone, but by the combination of EGF and TNFa treatments, indicating that doxazosin inhibits both EGFR and NF-kB signalling pathways to induce breast cancer cell apoptosis [160]. This evidence concerns the gene EGF and breast carcinoma.